S

Stylus Medicine

In vivo genome editing for CAR-T

Director Molecular & Cellular Immunology

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$225k - $240kIn-person

About the Job

Requirements

  • A PhD in Molecular Biology, Cellular Biology, Virology, Immunology, or a related field, with deep immunology expertise.
  • At least 8 years of post-graduate experience, including at least 5 years of drug discovery experience in the pharmaceutical or biotechnology industry.
  • A proven track record of leading immunology, immunotherapy, or engineered immune cell therapy programs from early drug discovery to IND, with CART experience.
  • A clear record of achievement demonstrated by accomplishments such as patents, new initiatives, IND preparation, and publications.
  • Expertise in immune-modulating molecule design and applying design-test-optimize cycles to functionally evaluate immune-relevant gene and cell therapy cargos.
  • Experience managing and developing scientists as direct reports.
  • Ability to collaborate across internal and external cross-functional teams.
  • Ability to think critically, synthesize simple principles from complex datasets, and communicate them effectively.

Responsibilities

  • Conceptualize in vivo T cell therapeutic product candidates using the Stylus non-viral recombinase engineering platform and develop molecular designs to realize those concepts.
  • Develop experimental strategies and immune cell-based testing systems to rigorously assess product candidate functional performance for development candidate nomination and preclinical data package generation.
  • Work closely with direct reports to focus experimental design and execution on key scientific questions and problems for the lead program and innovations, contributing hands-on in the lab as needed.
  • Lead, manage, mentor, and develop a team of direct-report scientists.
  • Apply immunology expertise in collaboration with multidisciplinary team members and external partners to execute programs consistent with overall strategy.
  • Communicate scientific concepts, strategies, status updates, and experimental results across the organization and to high-level stakeholders.
  • Deliver results with speed and rigor while maintaining awareness of timelines, milestones, and budgets.
  • Monitor the latest literature and technologies in the field to inspire or inform innovation, and present Stylus data externally as appropriate.
  • Lead or manage collaborations with academic, CRO, and corporate external partners to advance programs, as needed.

Desired Qualifications

  • Previous experience with T cell-engaging bispecific antibodies and antibody discovery.

About the Company

Stylus Medicine

In vivo genome editing for CAR-T

Stylus Medicine develops in vivo genetic medicines by combining engineered, therapeutic-grade recombinases with non-viral lipid nanoparticle (LNP) delivery. This platform enables sequence-specific genome integration to insert large genetic payloads directly inside a patient’s body, bypassing the complex steps of ex vivo cell modification. The initial focus is in oncology, delivering a recombinase and a CAR-encoding DNA payload to a patient’s T cells via LNP infusion, effectively turning the patient’s body into an in vivo CAR-T cell factory. The modular system can adapt CAR constructs to target different cancer antigens and holds potential for autoimmune and other genetic diseases beyond oncology. The company positions itself as an off-the-shelf, scalable genetic therapy approach that streamlines treatment workflows and broadens patient access by avoiding traditional ex vivo manufacturing.

Company size
11-50
Company stage
Series A
Total funding
$85M
Headquarters
Cambridge, MA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Stylus Medicine

See more jobs